153 related articles for article (PubMed ID: 2888045)
1. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.
Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR
Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
Haffmans J; Dzoljic MR
Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
[TBL] [Abstract][Full Text] [Related]
4. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
Dzoljic MR
NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.
Maldonado R; Fournié-Zaluski MC; Roques BP
Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):466-72. PubMed ID: 1620246
[TBL] [Abstract][Full Text] [Related]
6. Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome.
Maldonado R; Daugé V; Callebert J; Villette JM; Fournié-Zaluski MC; Feger J; Roques BP
Eur J Pharmacol; 1989 Jun; 165(2-3):199-207. PubMed ID: 2776828
[TBL] [Abstract][Full Text] [Related]
7. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
Livingston SJ; Sewell RD; Rooney KF; Smith HJ
Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
[TBL] [Abstract][Full Text] [Related]
10. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
[TBL] [Abstract][Full Text] [Related]
11. Physical dependence produced by chronic intracerebroventricular infusion of [D-Arg]kyotorphin or thiorphan to rats.
Bean AJ; Vaught JL
Eur J Pharmacol; 1984 Oct; 105(3-4):333-7. PubMed ID: 6096157
[TBL] [Abstract][Full Text] [Related]
12. Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord.
Dickenson AH; Sullivan AF; Fournie-Zaluski MC; Roques BP
Brain Res; 1987 Apr; 408(1-2):185-91. PubMed ID: 3474047
[TBL] [Abstract][Full Text] [Related]
13. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
[TBL] [Abstract][Full Text] [Related]
14. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
[TBL] [Abstract][Full Text] [Related]
15. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
Chipkin RE; Latranyi MB; Iorio LC
Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
[TBL] [Abstract][Full Text] [Related]
17. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
Ary M; Cox B; Lomax P
J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
[TBL] [Abstract][Full Text] [Related]
19. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
[TBL] [Abstract][Full Text] [Related]
20. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
